Teleflex Inc (TFX)
208.49
-2.72
(-1.29%)
USD |
NYSE |
Nov 04, 13:05
Teleflex Revenue (Quarterly): 764.38M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 764.38M |
| June 30, 2024 | 749.69M |
| March 31, 2024 | 737.85M |
| December 31, 2023 | 773.91M |
| September 30, 2023 | 746.39M |
| June 30, 2023 | 743.26M |
| March 31, 2023 | 710.93M |
| December 31, 2022 | 758.00M |
| September 30, 2022 | 686.79M |
| June 30, 2022 | 704.54M |
| March 31, 2022 | 641.72M |
| December 31, 2021 | 761.91M |
| September 30, 2021 | 700.25M |
| June 30, 2021 | 713.47M |
| March 31, 2021 | 633.92M |
| December 31, 2020 | 711.18M |
| September 30, 2020 | 628.30M |
| June 30, 2020 | 567.03M |
| March 31, 2020 | 630.64M |
| December 31, 2019 | 680.95M |
| September 30, 2019 | 648.32M |
| June 30, 2019 | 652.51M |
| March 31, 2019 | 613.58M |
| December 31, 2018 | 641.62M |
| September 30, 2018 | 609.67M |
| Date | Value |
|---|---|
| June 30, 2018 | 609.87M |
| March 31, 2018 | 587.23M |
| December 31, 2017 | 595.11M |
| September 30, 2017 | 534.70M |
| June 30, 2017 | 528.61M |
| March 31, 2017 | 487.88M |
| December 31, 2016 | 513.93M |
| September 30, 2016 | 455.65M |
| June 30, 2016 | 473.55M |
| March 31, 2016 | 424.89M |
| December 31, 2015 | 484.50M |
| September 30, 2015 | 443.71M |
| June 30, 2015 | 452.04M |
| March 31, 2015 | 429.43M |
| December 31, 2014 | 476.01M |
| September 30, 2014 | 457.17M |
| June 30, 2014 | 468.10M |
| March 31, 2014 | 438.55M |
| December 31, 2013 | 450.54M |
| September 30, 2013 | 413.80M |
| June 30, 2013 | 420.06M |
| March 31, 2013 | 411.88M |
| December 31, 2012 | 419.06M |
| September 30, 2012 | 368.05M |
| June 30, 2012 | 383.33M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
567.03M
Minimum
Jun 2020
773.91M
Maximum
Dec 2023
702.26M
Average
711.06M
Median
Revenue (Quarterly) Benchmarks
| Boston Scientific Corp | 4.209B |
| Haemonetics Corp | 336.17M |
| Globus Medical Inc | 629.69M |
| Edwards Lifesciences Corp | 1.354B |
| Halozyme Therapeutics Inc | 290.08M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 111.00M |
| Total Expenses (Quarterly) | 620.19M |
| EPS Diluted (Quarterly) | 2.36 |
| Enterprise Value | 11.32B |
| Gross Profit Margin (Quarterly) | 56.28% |
| Profit Margin (Quarterly) | 14.52% |
| Earnings Yield | 2.41% |
| Operating Earnings Yield | 4.08% |
| Normalized Earnings Yield | 2.880 |